Screening by mammography, women with a family history of breast cancer

被引:57
作者
Lalloo, F
Boggis, CRM
Evans, DGR
Shenton, A
Threlfall, AG
Howell, A [1 ]
机构
[1] Christie Hosp NHS Trust, Ctr Canc Epidemiol, Family Hist Clin, Manchester M20 4QL, Lancs, England
[2] Withington Hosp, Manchester Breast Screening Serv, Manchester M20 0PT, Lancs, England
关键词
screening (mammography); genetics; breast cancer; high risk women;
D O I
10.1016/S0959-8049(98)00005-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to describe the experience of screening women under the age of 50 years with a family history of breast cancer. 1259 women attended the Family History Clinic in Manchester for their first and subsequent consultations between 30 September 1992 and 30 April 1997. All women were under the age of 50 years at the initial consultation and had a lifetime risk of breast cancer of 1 in 6 or greater. Seven prevalent, seven incident and two interval cancers were detected. The number of invasive cancers expected to occur if this high risk population had not been screened was 8.45 (in 2722 person years at risk). 12 invasive cancers were detected, giving a ratio of 1.42 (95% confidence interval 0.73-2.48). The overall cancer detection rates in this young, at risk population were similar to those in older women in the National Health Service Breast Screening Programme. The number of cancers detected in the study was greater than expected in this population. As the numbers were small, a national trial needs to be undertaken to confirm these results and to determine the long term effects of screening. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:937 / 940
页数:4
相关论文
共 23 条
[1]  
CLAUS EB, 1991, AM J HUM GENET, V48, P232
[2]  
CLAUS EB, 1993, CANCER, V71, P147, DOI 10.1002/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO
[3]  
2-V
[4]  
CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO
[5]  
2-5
[6]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[7]  
Eisinger F, 1996, CANCER RES, V56, P471
[8]   OVERVIEW OF THE BIOLOGY AND MANAGEMENT OF DUCTAL CARCINOMA IN-SITU OF THE BREAST [J].
FRYKBERG, ER ;
BLAND, KI .
CANCER, 1994, 74 (01) :350-361
[9]   SCREENING AND GENETIC-COUNSELING FOR RELATIVES OF PATIENTS WITH BREAST-CANCER IN A FAMILY CANCER CLINIC [J].
HOULSTON, RS ;
LEMOINE, L ;
MCCARTER, E ;
HARRINGTON, S ;
MACDERMOT, K ;
HINTON, J ;
BERGER, L ;
SLACK, J .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (10) :691-694
[10]   Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas [J].
Kelsell, DP ;
Spurr, NK ;
Barnes, DM ;
Gusterson, B ;
Bishop, DT .
LANCET, 1996, 347 (9014) :1554-1555